Main menu
Edison Group
  • Home
  • Sparks
  • Equities

    Equities

    View All Equities

    Equities by Sector

    Metals One

    MCap

    —

    Last close

    GBP0.01

    ▲ 0.18 (19.44%)

    Argent Biopharma

    MCap

    AUD7m

    Last close

    AUD0.09

    ▲ 0.01 (17.33%)

    ADS-TEC Energy

    MCap

    USD627m

    Last close

    USD10.55

    ▲ −0.88 (−7.66%)

  • Sectors

    Sectors

  • Thematics

    Thematics

    View All Thematics

    Latest

  • Audiovisual

    Audiovisual

    View All Audiovisual

    Latest

Bitesize briefing – clinical trials, outcomes and endpoints

Bitesize briefing – clinical trials, outcomes and endpoints

In this briefing Sabah Meddings of the Sunday Times and healthcare analyst Andy Smith discuss his recent note, Trial outcomes and value – explaining contemporary clinical trial issues. They discuss how the detail of pharmaceutical and biotechnology company clinical trials is relevant to investors. They also touch on the debate surrounding the confidentiality of interactions between drug sponsors and regulators and whether this is material to investors.

< Previous
Next >

You may also be interested in these:

TMT

Waymap – executive interview

Healthcare

Herantis Pharma – executive interview